Bortezomib and belinostat inhibit renal cancer growth synergistically by causing ubiquitinated protein accumulation and endoplasmic reticulum stress
Publisher: Science Publishers
ISSN: 2049-9434
Source: Biomedical Reports, Vol.3, Iss.6, 2015-01, pp. : 797-801
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract